Can homocysteine be elevated despite normal serum B12 and folate?

An elevated homocysteine level can occur even when standard serum vitamin B12 and folate concentrations appear normal, as routine blood tests do not capture intracellular utilization, cofactor availability, or systemic clearance rates.

Intracellular and genetic bottlenecks

Standard serum tests measure total circulating cobalamin, much of which is inactive and bound to haptocorrin. This misses critical intracellular deficits:

• Cellular delivery limits: Cellular uptake requires B12 to bind transcobalamin to form active holotranscobalamin (holoTC). The TCN2 776C>G (rs1801198) polymorphism reduces this binding affinity, limiting intracellular cobalamin delivery and restricting methionine synthase activity.
• Recycling inefficiency: Active methylcobalamin must be continuously regenerated. The MTRR rs1801394 (A66G) variant alters the enzyme's binding domain, slowing cobalamin recycling and causing functional intracellular B12 deficiency.

Alternate pathway and cofactor dynamics

When folate- or B12-dependent remethylation is compromised, alternative enzymatic pathways and mineral cofactors dictate homocysteine levels:

• Betaine-pathway capacity: The liver and kidneys utilize betaine-homocysteine S-methyltransferase (BHMT) as a parallel, cobalamin-independent remethylation pathway. Suboptimal betaine/choline intake or BHMT genetic variants (such as rs3733890) limit this metabolic bypass, raising systemic homocysteine.
• Magnesium availability: Magnesium is an essential cofactor for methionine adenosyltransferase (MAT). Intracellular magnesium depletion impairs MAT activity, disrupting upstream methionine cycle dynamics and hindering subsequent transsulfuration.

Systemic clearance and thyroid influence

Thyroid hormone deficiency drives systemic homocysteine accumulation through renal and enzymatic mechanisms:

• Enzymatic downregulation: Hypothyroidism downregulates riboflavin kinase, decreasing the flavin adenine dinucleotide (FAD) cofactors required for MTHFR activity.
• Renal clearance: Thyroid deficiency impairs renal hemodynamics, reducing the glomerular filtration rate (GFR) and directly compromising the kidneys' ability to filter and metabolize homocysteine.

Bottom line

• Normal serum B12 and folate levels do not guarantee functional pathway efficiency. Elevated homocysteine can be driven by genetic blocks in cellular B12 transport (TCN2) or recycling (MTRR), impaired alternative remethylation (BHMT, magnesium-dependent MAT), and thyroid-driven clearance deficits.